Harbour Investments, Inc. Bellerophon Therapeutics, Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$2.36 - $4.05 $568 - $976	-241 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.75 - $4.86 $371 - $481	99 Added 69.72%	241 $1,000
Q2 2021 Aug 16, 2021	BUY	$3.83 - $5.65 $15 - $22	4 Added 2.9%	142 $1,000
Q1 2021 Aug 17, 2021	BUY	$5.07 - $8.27 $699 - $1,141	138 New	138 $1,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $477K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.